WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 4 fonti

Adoption of generic semaglutide depends on the delivery device

The adoption of generic semaglutide in India hinges on the clarity and simplicity of its delivery devices.

Raccontata dathehindubusinessline.comthehindu.comeconomictimes.indiatimes.combusinessday.co.za

Confronto fonti

4 prospettive sulla stessa storia
AI · summaries
thehindubusinessline.comStai leggendo3 g fa

Adoption of generic semaglutide depends on the delivery device

The adoption of generic semaglutide in India hinges on the clarity and simplicity of its delivery devices.

originale
thehindu.com1 g fa

Why Semaglutide is an inflection point for India’s generics sector?

Discover how the Semaglutide episode could reshape India's generics sector, revealing vulnerabilities and opportunities for future growth.

Leggi questa versione → originale
economictimes.indiatimes.com1 g fa

Sun Pharma gets SAHPRA approval for generic semaglutide injection in South Africa for type 2 diabetes

South Africa's regulator approved Sun Pharma's generic semaglutide injection for diabetes. This approval allows marketing to supplement diet and exercise for adults. The company plans to launch the product soon in…

Leggi questa versione → originale
businessday.co.za1 g fa

India’s Sun Pharma wins South Africa approval to launch generic Ozempic

South Africa is now the second market, after India, where the company has secured clearance for a generic semaglutide injection

Leggi questa versione → originale

Timeline cronologica

  1. lunedì 13 luglio 2026·thehindubusinessline.com

    Adoption of generic semaglutide depends on the delivery device

    The adoption of generic semaglutide in India hinges on the clarity and simplicity of its delivery devices.

  2. mercoledì 15 luglio 2026·thehindu.com

    Why Semaglutide is an inflection point for India’s generics sector?

    Discover how the Semaglutide episode could reshape India's generics sector, revealing vulnerabilities and opportunities for future growth.

  3. mercoledì 15 luglio 2026·thehindubusinessline.com

    Sun Pharma gets go-ahead to sell generic semaglutide in South Africa

    The approval is to treat Type II diabetes

  4. mercoledì 15 luglio 2026·economictimes.indiatimes.com

    Sun Pharma gets SAHPRA approval for generic semaglutide injection in South Africa for type 2 diabetes

    South Africa's regulator approved Sun Pharma's generic semaglutide injection for diabetes. This approval allows marketing to supplement diet and exercise for adults. The company…

  5. mercoledì 15 luglio 2026·thehindu.com

    Sun Pharma gets nod from South African regulator for generic semaglutide injection

    Sun Pharma receives SAHPRA approval to market a generic semaglutide injection for type 2 diabetes in South Africa.

  6. mercoledì 15 luglio 2026·businessday.co.za

    India’s Sun Pharma wins South Africa approval to launch generic Ozempic

    South Africa is now the second market, after India, where the company has secured clearance for a generic semaglutide injection